Monika Drobniene Selected Research

tetraphenylphosphonium (tetraphenylphosphonium chloride)

1/2021

Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monika Drobniene Research Topics

Disease

2	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2014
1	Neoplasms (Cancer) 01/2021

Drug/Important Bio-Agent (IBA)

1	tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021

Therapy/Procedure

1	Treatment Delay 10/2014